Smith Group Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Smith Group Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-28,840	Closed	-$1.77M	–	418
2014 Q3	$1.77M	Sell	28,840 -60	-0.2%	-$2.59K	0.07%	160
2014 Q2	$1.32M	Buy	+28,900	New	+$1.18M	0.05%	171

Other funds holding AGIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return